Medical Bud News
SEE OTHER BRANDS

Your CBD news reporter

Press Releases

Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Medical Bud News.

Cannabinoid Agonist Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

Cannabinoid Agonist Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

New York, USA, July 10, 2025 (GLOBE NEWSWIRE) -- Cannabinoid Agonist Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight The cannabinoid agonist market is gaining...

Behavioral Rehabilitation Market Surpasses USD 171.88 Billion in 2025, Fueled by Anxiety and Substance Abuse Disorders

Behavioral Rehabilitation Market Surpasses USD 171.88 Billion in 2025, Fueled by Anxiety and Substance Abuse Disorders

Ottawa, July 10, 2025 (GLOBE NEWSWIRE) -- The global behavioral rehabilitation market size was valued at USD 165.94 billion in 2024 and is predicted to hit around USD 235.89 billion by 2034, a study published by Towards Healthcare a sister firm of...

Artelo Biosciences Announces Positive Preclinical Efficacy Data for ART26.12 in Osteoarthritis Pain at the 35th Annual International Cannabinoid Research Society Symposium

Artelo Biosciences Announces Positive Preclinical Efficacy Data for ART26.12 in Osteoarthritis Pain at the 35th Annual International Cannabinoid Research Society Symposium

SOLANA BEACH, Calif., July 09, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain,...

Artelo Biosciences Announces Positive Preclinical Efficacy with ART12.11 in Stress-Induced Depression Model

Artelo Biosciences Announces Positive Preclinical Efficacy with ART12.11 in Stress-Induced Depression Model

ART12.11, the Patented CBD:TMP Cocrystal, Demonstrates Potent Antidepressant-Like Activity and Cognitive Benefits Over Leading SSRI Data Being Presented at the 35th Annual International Cannabinoid Research Society Symposium SOLANA BEACH, Calif.,...

Cannabis Extract Market Generated Opportunities, Future Scope 2025-2032 | Canopy Growth Corporation, Aurora Cannabis Inc

Cannabis Extract Market Generated Opportunities, Future Scope 2025-2032 | Canopy Growth Corporation, Aurora Cannabis Inc

BURLINGAME, CA, UNITED STATES, June 26, 2025 /⁨EINPresswire.com⁩/ -- Cannabis Extract Market is estimated to be valued at USD 14.56 Bn in 2025 and is expected to reach USD 45.32 Bn by 2032, growing at a compound annual growth rate (CAGR) of 17.6%...

Highest THCa Flower July 2025: New Hemp Hop Strains Hit the Market

Highest THCa Flower July 2025: New Hemp Hop Strains Hit the Market

CHARLOTTE, N.C., July 02, 2025 (GLOBE NEWSWIRE) -- Hemp Hop has announced the launch of 2 new high-THCa strains - London Jealousy and Gravel Pit. As demand for the best exotic THCa flower continues to grow, Hemp Hop expands its lineup with...

Missouri’s Division of Cannabis Regulation announces recall for cannabis products produced by Bootheel CannaCare Columbia LLC, MAN000030

Missouri’s Division of Cannabis Regulation announces recall for cannabis products produced by Bootheel CannaCare Columbia LLC, MAN000030

For Immediate Release: July 1, 2025 Media Contact: Lisa Cox Missouri Department of Health and Senior Services Media Inquiry Form JEFFERSON CITY, MO -- The Missouri Division of Cannabis Regulation (DCR), in partnership with Bootheel CannaCare...

Artelo Biosciences Announces Positive First-in-Human Data for ART26.12, a Novel Non-Opioid Treatment Candidate for Persistent Pain

Artelo Biosciences Announces Positive First-in-Human Data for ART26.12, a Novel Non-Opioid Treatment Candidate for Persistent Pain

First Orally Active Fatty Acid Binding Protein 5 Inhibitor Evaluated in Humans First-in-Class Approach Targets Unmet Need in Multibillion-Dollar Pain Management Market SOLANA BEACH, Calif., June 30, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences,...

CBD Patches Market is Expected to Grow at US$ 691.9 Million by 2033 | Fact.MR

CBD Patches Market is Expected to Grow at US$ 691.9 Million by 2033 | Fact.MR

Analysis of CBD Patches Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea ROCKVILLE , MD, UNITED STATES, June 19, 2025 /⁨EINPresswire.com⁩/ -- The global CBD patches market,...

Medicinal Cannabis Market Is Booming So Rapidly 2025-2032 | BOL Pharma, Tilray, Medreleaf Corporation

Medicinal Cannabis Market Is Booming So Rapidly 2025-2032 | BOL Pharma, Tilray, Medreleaf Corporation

Medicinal Cannabis Market is estimated to valued USD 23.93 Bn in 2025 and expected reach USD 102.58 Bn by 2032, growing at CAGR of 23.1% from 2025 to 2032. BURLINGAME, CA, UNITED STATES, June 26, 2025 /⁨EINPresswire.com⁩/ -- Medicinal Cannabis...

Tilray Medical Publishes Pioneering Research on the Pharmacokinetics of THC and CBD Formulations

Tilray Medical Publishes Pioneering Research on the Pharmacokinetics of THC and CBD Formulations

NEW YORK, June 26, 2025 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY) and a global leader in medical cannabis, empowering the therapeutic alliance between patients and...

Canada Weed Control Market Analysis: Key Trends, Share, Growth Drivers, And Forecast 2025-2034

Canada Weed Control Market Analysis: Key Trends, Share, Growth Drivers, And Forecast 2025-2034

The Business Research Company's Canada Weed Control Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 24, 2025 /⁨EINPresswire.com⁩/ -- The Canada weed control report...

Expanding Access to Medical Cannabis: How Online MMJ Card Renewal is Reshaping Healthcare in Virginia

Expanding Access to Medical Cannabis: How Online MMJ Card Renewal is Reshaping Healthcare in Virginia

Online MMJ card renewal is transforming medical cannabis access in Virginia—streamlining care, improving compliance, and reaching underserved communities. MIDLOTHIAN, VA, UNITED STATES, June 23, 2025 /⁨EINPresswire.com⁩/ -- Access to medical...

Incannex Healthcare Expands Clinical Advisory Board to Support Obstructive Sleep Apnea Program with Appointment of Dr. Douglas B. Kirsch

Incannex Healthcare Expands Clinical Advisory Board to Support Obstructive Sleep Apnea Program with Appointment of Dr. Douglas B. Kirsch

NEW YORK and MELBOURNE, Australia, June 24, 2025 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL) (“Incannex” or the “Company”), a clinical-stage biopharmaceutical company advancing combination drug therapies for high-impact...

Three Michigan Dispensaries Set New Standards in Cannabis Retail

Three Michigan Dispensaries Set New Standards in Cannabis Retail

Vive Cannabis Co., Luxury Loud, and Twisted Bee Highlight Local Ownership, Community Investment, and Product Transparency DETROIT, MI, UNITED STATES, June 19, 2025 /⁨EINPresswire.com⁩/ -- As Michigan’s cannabis industry matures, a new generation...

Big League Genetics Licenses 3R Biotech’s Clean Cannabis Tissue Culture Platform

Big League Genetics Licenses 3R Biotech’s Clean Cannabis Tissue Culture Platform

Big League Genetics partners with 3R Biotech to eliminate disease risk and scale clean cannabis genetics through a licensed tissue culture platform. VANCOUVER, CANADA, June 18, 2025 /⁨EINPresswire.com⁩/ -- Big League Genetics Licenses 3 Rivers...

Rafael Holdings Announces Continuation of its Phase 3 Study for the Treatment of Niemann-Pick Disease Type C1 (NPC1) Following Independent Data Monitoring Committee (DMC) Review of Prespecified 48-Week Interim Data

Rafael Holdings Announces Continuation of its Phase 3 Study for the Treatment of Niemann-Pick Disease Type C1 (NPC1) Following Independent Data Monitoring Committee (DMC) Review of Prespecified 48-Week Interim Data

Phase 3 TransportNPC study to continue based on the independent DMC review of safety and efficacy data at prespecified 48-week interim analysis Data on the investigational candidate Trappsol® Cyclo™ (hydroxypropyl-beta-cyclodextrin), indicates...

Rising Chronic Disease Cases Drive Growth: Key Trends Reshaping the Appetite Stimulants Market in 2025

Rising Chronic Disease Cases Drive Growth: Key Trends Reshaping the Appetite Stimulants Market in 2025

The Business Research Company's Rising Chronic Disease Cases Drive Growth: Key Trends Reshaping the Appetite Stimulants Market in 2025 LONDON, GREATER LONDON, UNITED KINGDOM, June 16, 2025 /⁨EINPresswire.com⁩/ -- The Business Research Company’s...

Green Stop Wellness Warns Senate Bill 3 Will Harm Small Businesses, Cannabis Access for Texans in Need

Green Stop Wellness Warns Senate Bill 3 Will Harm Small Businesses, Cannabis Access for Texans in Need

HOUSTON, TX, UNITED STATES, June 17, 2025 /⁨EINPresswire.com⁩/ -- Green Stop Wellness, a leading Houston-based dispensary and advocate for holistic healing and wellness in Texas, is deeply concerned about the recent passage of Senate Bill 3, which...

Dr. Bernard Fialkoff presents Scientific Findings Regarding Vaping, Marijuana, Opioid Gateways to Addiction / Dependency

Dr. Bernard Fialkoff presents Scientific Findings Regarding Vaping, Marijuana, Opioid Gateways to Addiction / Dependency

Dr. Bernard Fialkoff presents Scientific Findings Regarding Vaping, Marijuana, Opioid Gateways to Albany Dentists on Predisposition to Addiction / Dependency ALBANY, NY, UNITED STATES, June 16, 2025 /⁨EINPresswire.com⁩/ -- Should Health...

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service